Estrella Immunopharma (ESLA)

• Market cap: $31.1M
• 1 day: -0.19%
• 5 days: 0.44%
• 1 month: -11.37%
• 3 months: -40.23%
• 6 months: -43.5%
• Year to date: -47.97%
• 1 year: -15.95%
• 5 years: -92.58%
• 10 years: -92.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.